Sanofi India Share Price
3163.70-27.10 (-0.85%)
-38.33% past 1 Year
News
Sanofi India projects operating cost reductions while sustaining insulin revenue growth
Equity
SANOFI
Sanofi India guides robust diabetes unit growth with medium-term outlook
Equity
SANOFI
Sanofi India Q1 FY earnings show strong EBITDA growth and margin expansion
Equity
SANOFI
Sanofi India Q1 revenue rises year on year to Rs 438 crores
Equity
SANOFI
Sanofi India Q1 profit rises year-on-year on stronger earnings performance
Equity
SANOFI
Sanofi India NSE block trade of Rs 25.13 crores at Rs 3398
Equity
SANOFI
Sanofi India announces planned CFO transition effective September 30, 2026
Equity
SANOFI
Sanofi India sees Rs 40.24 crore BSE block trade at Rs 3353
Equity
SANOFI
Sanofi India appoints Rahul Bhatnagar as new Chairman succeeding Aditya Narayan.
Equity
SANOFI
Sanofi India Q4 EBITDA Declines to Rs 140 Crores, Margin Contracts to 30.24%
Equity
SANOFI
Sanofi India Q4 FY Results: Net Profit Down 17% YoY to Rs 100 Crores, Revenue Falls 13% to Rs 470 Crores.
Equity
SANOFI
Sanofi India Board Calls 70th AGM on April 29, 2026, Recommends Rs 48 Final Dividend, Appoints New Independent Director.
Equity
SANOFI
Sanofi India Suggests Final Dividend of Rs 48 Per Share.
Equity
SANOFI
Sanofi India Q3 EBITDA Declines to Rs 90.30 Crores, Margin Contracts to 21.51% YoY.
Equity
SANOFI
Sanofi India Q3 FY25 Results: Net Profit Declines 32% YoY to Rs 61.70 Crores, Revenue Down 18% to Rs 420 Crores.
Equity
SANOFI
Sanofi India Expands Hyderabad GCC to Support 2,600 Employees with €400 Million Investment.
Equity
SANOFI
Sanofi India Receives Multiple Tax Demand Orders Totaling Rs 1.43 Crores for FY2018-19
Equity
SANOFI
Sanofi India targets growth via diabetes portfolio, specialty launches, and local manufacturing.
Equity
SANOFI
Sanofi India Q2 EBITDA up 11.7% YoY at Rs 134 crore, margin expands to 28.23%
Equity
SANOFI
Sanofi India Q2 FY2025 net sales fall 9% YoY; operating profit rises, export headwinds cited.
Equity
SANOFI